Clinical Scorecard: A Picture of Positivity: Sitting Down With Georgios Theodoridis
At a Glance
| Category | Detail |
|---|---|
| Condition | Analytical Science |
| Key Mechanisms | High-performance liquid chromatography (HPLC) and mass spectrometry (MS) techniques |
| Target Population | Students and practitioners in analytical chemistry and related fields |
| Care Setting | Academic and clinical laboratories |
Key Highlights
- HPLC remains a valid and widely used technique in clinical labs.
- Fundamental knowledge in physical chemistry is crucial for avoiding common mistakes in chromatography.
- Metabolomics is expected to become a significant part of standard clinical practice.
- Current focus on type 2 diabetes highlights the complexity of the disease and the role of metabolomics.
- ThetaBiomarkers aims to develop biomarker panels for clinical decision-making.
Guideline-Based Recommendations
Diagnosis
- Utilize metabolomics to reveal complexities in diseases like type 2 diabetes.
Management
- Develop technology-ready methods for clinical applications.
Monitoring & Follow-up
- Analyze thousands of samples to validate methods for clinical use.
Risks
- Lack of fundamental knowledge can lead to errors in analytical results.
Patient & Prescribing Data
Individuals with type 2 diabetes and metabolic syndrome.
Metabolomics can accurately monitor disease and therapeutic interventions.
Clinical Best Practices
- Ensure practitioners have a strong understanding of chromatography principles.
- Encourage collaboration between analytical scientists and clinicians.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
